THE ANTICOAGULATION STRATEGIES FOR MANAGEMENT AND PREVENTION OF STROKE IN NEUROLOGICAL PRACTICE

Mujahed Measar; Ali Alyahawi

doi:10.22270/ujpr.v9i4.1159

Mujahed Measar Faculty of Medicine, 21 September University for Medical and Applied Sciences, Yemen.
Ali Alyahawi Faculty of Clinical Pharmacy, 21 September University for Medical & Applied Sciences, Yemen.

10.22270/ujpr.v9i4.1159

Keywords:

Anticoagulants, atrial fibrillation, cerebral hemorrhage, ischemic stroke

Abstract

Strokes are categorized as either ischemic or hemorrhagic and the specific interventions will be based on the type of stroke. About 13% of stroke is hemorrhagic and 87% is ischemic. Transient Ischemic Attacks require emergency intervention to decrease the threat of stroke, which is thought to be maximum within the first few days after TIA. Anticoagulants play a major role in the primary and secondary prevention of ischemic strokes.

The optimal timing of anticoagulants initiation or resumption inpreventing and managing ischemic strokes is very important. This article will explore certain controversies surrounding this issue, while also highlighting the benefits of antithrombotic therapy used in prevention of ischemic strokes in antiphospholipid antibody syndrome (APS), atrial fibrillation, prosthetic heart valve, cancer, and vascular disorders. Aggressive local and regional efforts to organize stroke care and greater use of evidence-based recommendations may help improve outcomes.